HomeENZN • OTCMKTS
Enzon Pharmaceuticals Inc
$0.11
2.32%
-0.0025 Today
Apr 3, 12:18:51 AM UTC-4 · USD · OTCMKTS · Disclaimer
In the news
Financials
Income Statement
0200K400K600K
Revenue
Net Income
Revenue
Net income
(USD)Dec 2024Y/Y change
Revenue
0.00
Operating expense
325.00K50.46%
Net income
-72.00K-110.71%
Net profit margin
Earnings per share
EBITDA
Effective tax rate
132.58%
020M40M
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD)Dec 2024Y/Y change
Cash and short-term investments
46.86M-0.33%
Total assets
47.17M-1.12%
Total liabilities
1.68M-2.10%
Total equity
45.49M
Shares outstanding
74.21M
Price to book
2.74
Return on assets
-1.72%
Return on capital
-1.76%
-1M-500K0
Net Change in Cash
Net change in cash
(USD)Dec 2024Y/Y change
Net income
-72.00K-110.71%
Cash from operations
226.00K-50.33%
Cash from investing
Cash from financing
0.00
Net change in cash
226.00K-50.33%
Free cash flow
1.08M-7.70%
StockUS listed securityUS headquartered
Previous close
$0.11
Day range
$0.080 - $0.11
Year range
$0.062 - $0.24
Market cap
7.95M USD
Avg Volume
70.27K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
About
Enzon Pharmaceuticals, Inc. is a pharmaceutical company. Its headquarters is in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the symbol "ENZN". It's also doing marketing works in Asia areas such as China. In 2012, the company orally presented in Nanjing, China about the symposium of its drug delivery systems, which help improve therapeutic molecules' pharmaceutical properties. Wikipedia
Founded
1981
Website
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Main menu
Google apps